These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36931740)

  • 1. Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics.
    Abele N; Tiemann K; Krech T; Wellmann A; Schaaf C; Länger F; Peters A; Donner A; Keil F; Daifalla K; Mackens M; Mamilos A; Minin E; Krümmelbein M; Krause L; Stark M; Zapf A; Päpper M; Hartmann A; Lang T
    Mod Pathol; 2023 Mar; 36(3):100033. PubMed ID: 36931740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases.
    Jung M; Song SG; Cho SI; Shin S; Lee T; Jung W; Lee H; Park J; Song S; Park G; Song H; Park S; Lee J; Kang M; Park J; Pereira S; Yoo D; Chung K; Ali SM; Kim SW
    Breast Cancer Res; 2024 Feb; 26(1):31. PubMed ID: 38395930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.
    Tuominen VJ; Ruotoistenmäki S; Viitanen A; Jumppanen M; Isola J
    Breast Cancer Res; 2010; 12(4):R56. PubMed ID: 20663194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application Test of the AI-Automatic Diagnostic System for Ki-67 in Breast Cancer].
    Deng Y; Li FL; Qin HY; Zhou YY; Zhou QQ; Mei J; Li L; Liu HH; Wang YZ; Bu H; Bao J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):693-697. PubMed ID: 34323051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.
    Gertych A; Mohan S; Maclary S; Mohanty S; Wawrowsky K; Mirocha J; Balzer B; Knudsen BS
    Diagn Pathol; 2014 Nov; 9():213. PubMed ID: 25421113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of methods for accurate recognition of cells through nuclei staining of Ki-67 in neuroblastoma and estrogen/progesterone status staining in breast cancer.
    Markiewicz T; Wisniewski P; Osowski S; Patera J; Kozlowski W; Koktysz R
    Anal Quant Cytol Histol; 2009 Feb; 31(1):49-62. PubMed ID: 19320193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification.
    Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
    JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology.
    Paulik R; Micsik T; Kiszler G; Kaszál P; Székely J; Paulik N; Várhalmi E; Prémusz V; Krenács T; Molnár B
    Cytometry A; 2017 Jun; 91(6):595-608. PubMed ID: 28472544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
    Pu T; Shui R; Shi J; Liang Z; Yang W; Bu H; Li Q; Zhang Z;
    BMC Cancer; 2019 Oct; 19(1):978. PubMed ID: 31640622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital validation of breast biomarkers (ER, PR, AR, and HER2) in cytology specimens using three different scanners.
    Salama AM; Hanna MG; Giri D; Kezlarian B; Jean MH; Lin O; Vallejo C; Brogi E; Edelweiss M
    Mod Pathol; 2022 Jan; 35(1):52-59. PubMed ID: 34518629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer.
    Krecsák L; Micsik T; Kiszler G; Krenács T; Szabó D; Jónás V; Császár G; Czuni L; Gurzó P; Ficsor L; Molnár B
    Diagn Pathol; 2011 Jan; 6():6. PubMed ID: 21244664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence algorithm accurately assesses oestrogen receptor immunohistochemistry in metastatic breast cancer cytology specimens: A pilot study.
    Li BC; Hammond S; Parwani AV; Shen R
    Cytopathology; 2024 Jul; 35(4):464-472. PubMed ID: 38519745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring.
    Engelberg JA; Retallack H; Balassanian R; Dowsett M; Zabaglo L; Ram AA; Apple SK; Bishop JW; Borowsky AD; Carpenter PM; Chen YY; Datnow B; Elson S; Hasteh F; Lin F; Moatamed NA; Zhang Y; Cardiff RD
    Hum Pathol; 2015 Nov; 46(11):1694-704. PubMed ID: 26410019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
    Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
    Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Ki67 assessment concordance by the use of an artificial intelligence-empowered microscope: a multi-institutional ring study.
    Cai L; Yan K; Bu H; Yue M; Dong P; Wang X; Li L; Tian K; Shen H; Zhang J; Shang J; Niu S; Han D; Ren C; Huang J; Han X; Yao J; Liu Y
    Histopathology; 2021 Oct; 79(4):544-555. PubMed ID: 33840132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study.
    Yue M; Zhang J; Wang X; Yan K; Cai L; Tian K; Niu S; Han X; Yu Y; Huang J; Han D; Yao J; Liu Y
    Virchows Arch; 2021 Sep; 479(3):443-449. PubMed ID: 34279719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully Automated Artificial Intelligence Solution for Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Scoring in Breast Cancer: A Multireader Study.
    Krishnamurthy S; Schnitt SJ; Vincent-Salomon A; Canas-Marques R; Colon E; Kantekure K; Maklakovski M; Finck W; Thomassin J; Globerson Y; Bien L; Mallel G; Grinwald M; Linhart C; Sandbank J; Vecsler M
    JCO Precis Oncol; 2024 Oct; 8():e2400353. PubMed ID: 39393036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Ki-67 labeling index measurements using digital image analysis and scoring by pathologists.
    Morioka T; Niikura N; Kumaki N; Masuda S; Iwamoto T; Yokoyama K; Ogiya R; Oshitanai R; Terao M; Tsuda B; Okamura T; Saito Y; Suzuki Y; Tokuda Y
    Breast Cancer; 2018 Nov; 25(6):768-777. PubMed ID: 29959636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer.
    Cserni B; Bori R; Csörgő E; Oláh-Németh O; Pancsa T; Sejben A; Sejben I; Vörös A; Zombori T; Nyári T; Cserni G
    Virchows Arch; 2021 Dec; 479(6):1101-1109. PubMed ID: 34415429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.